Nuwellis (NUWE) Liabilities and Shareholders Equity (2011 - 2026)
Nuwellis posted quarterly Liabilities and Shareholders Equity of $7.0 million for Q1 2026, down 0.64% year-on-year from $7.0 million in Q1 2025, and up 13.78% on a QoQ basis from $6.1 million in Q4 2025.
Nuwellis (NUWE) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $7.0 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 0.64% year-over-year to $7.0 million; the trailing twelve-month figure through Mar 2026 stood at $30.3 million (up 1.6% YoY), and the FY2025 full-year result was $6.1 million, down 37.98% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $7.0 million, up from $6.1 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $26.1 million in Q1 2022 and bottomed at $6.1 million in Q4 2025.
- The 5-year median for Liabilities and Shareholders Equity is $9.8 million (2023), against an average of $12.5 million.
- The widest annual swing landed in 2024, when Liabilities and Shareholders Equity tumbled 63.95%; it then soared 48.65% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $24.7 million in 2022, then tumbled by 60.4% to $9.8 million in 2023, then rose by 0.96% to $9.9 million in 2024, then plunged by 37.98% to $6.1 million in 2025, then climbed by 13.78% to $7.0 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $7.0 million (Q1 2026), $6.1 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | 6.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.96 Mn |
| Dec 31, 2025 | 6.12 Mn |
| Sep 30, 2025 | 7.98 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Mar 31, 2025 | 7.01 Mn |
| Dec 31, 2024 | 9.86 Mn |
| Sep 30, 2024 | 6.73 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Mar 31, 2024 | 6.66 Mn |
| Dec 31, 2023 | 9.77 Mn |
| Sep 30, 2023 | 11.43 Mn |
| Jun 30, 2023 | 15.55 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 24.67 Mn |
| Sep 30, 2022 | 18.44 Mn |
| Jun 30, 2022 | 22.00 Mn |
| Mar 31, 2022 | 26.11 Mn |
| Dec 31, 2021 | 30.42 Mn |
| Sep 30, 2021 | 34.10 Mn |
| Jun 30, 2021 | 29.64 Mn |
| Mar 31, 2021 | 33.56 Mn |
| Dec 31, 2020 | 20.01 Mn |
| Sep 30, 2020 | 23.72 Mn |
| Jun 30, 2020 | 13.14 Mn |
| Mar 31, 2020 | 10.05 Mn |
| Dec 31, 2019 | 5.60 Mn |
| Sep 30, 2019 | 7.58 Mn |
| Jun 30, 2019 | 11.43 Mn |
| Mar 31, 2019 | 15.36 Mn |
| Dec 31, 2018 | 8.78 Mn |
| Sep 30, 2018 | 11.79 Mn |
| Jun 30, 2018 | 10.94 Mn |
| Mar 31, 2018 | 14.41 Mn |
| Dec 31, 2017 | 18.46 Mn |
| Sep 30, 2017 | 9.34 Mn |
| Jun 30, 2017 | 11.81 Mn |
| Mar 31, 2017 | 7.82 Mn |
| Dec 31, 2016 | 7.47 Mn |
| Sep 30, 2016 | 6.62 Mn |
| Jun 30, 2016 | 13.00 Mn |
| Mar 31, 2016 | 17.78 Mn |
| Dec 31, 2015 | 24.45 Mn |
| Sep 30, 2015 | 29.37 Mn |
| Jun 30, 2015 | 34.91 Mn |
| Mar 31, 2015 | 38.80 Mn |
| Dec 31, 2014 | 32.37 Mn |
| Sep 30, 2014 | 37.79 Mn |
| Jun 30, 2014 | 43.37 Mn |
| Mar 31, 2014 | 48.88 Mn |
| Dec 31, 2013 | 55.23 Mn |
| Sep 30, 2013 | 60.81 Mn |
| Jun 30, 2013 | 22.64 Mn |
| Mar 31, 2013 | 11.92 Mn |
| Dec 31, 2012 | 15.04 Mn |
| Sep 30, 2012 | 18.61 Mn |
| Jun 30, 2012 | 2.91 Mn |
| Mar 31, 2012 | 5.00 Mn |
| Dec 31, 2011 | 7.43 Mn |